These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5336998)

  • 1. Antinuclear antibodies: diagnostic significance and methods.
    Friou GJ
    Arthritis Rheum; 1967 Apr; 10(2):151-9. PubMed ID: 5336998
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunofluorescent tumor imprint technic. 3. The diagnostic and prognostic significance of the "speckle"-inducing antinuclear antibody.
    Burnham TK; Neblett TR; Fine G
    Am J Clin Pathol; 1968 Dec; 50(6):683-8. PubMed ID: 4881946
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic aspects of lupus erythematosus cells and antinuclear factors in disease states.
    Barnett EV
    Mayo Clin Proc; 1969 Sep; 44(9):645-8. PubMed ID: 4186061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic lupus erythematosus, the significance of immunologic tests].
    Michelsen B
    Z Hautkr; 1986 May; 61(10):667-70. PubMed ID: 2424185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fluorescence microscopic demonstration of antinuclear factors in lupus erythematosus and related diseases].
    Havemann K; Arend P
    Klin Wochenschr; 1966 Jan; 44(1):19-25. PubMed ID: 4862074
    [No Abstract]   [Full Text] [Related]  

  • 6. Antinuclear antibodies: role in diagnosing systemic lupus erythrmatosus.
    Niejadlik DC
    Postgrad Med; 1971 Sep; 50(3):273-7. PubMed ID: 4937319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunofluorescent technic to detect antinuclear factors].
    Cossio PM; Arana R; Garcia Morteo O
    Prensa Med Argent; 1968 Aug; 55(27):1302-6. PubMed ID: 4883211
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic tests for systemic lupus erythematosus.
    Mani RM; Trikannad VS; Batlivala PM; Krishnaswamy PR
    J Assoc Physicians India; 1980 Nov; 28(11):451-5. PubMed ID: 6163759
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement.
    Mevorach D; Raz E; Steiner I
    Lupus; 1994 Apr; 3(2):117-21. PubMed ID: 7920611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic tests and clinical subsets in systemic lupus erythematosus: update 1983.
    Weiss RA; Mogavero HS; Synkowski DR; Provost TT
    Ann Allergy; 1983 Aug; 51(2 Pt 1):135-46. PubMed ID: 6349429
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of nuclear immunofluorescent patterns.
    Dorsch CA; Gibbs CB; Stevens MB; Shulman LE
    Ann Rheum Dis; 1969 May; 28(3):313-9. PubMed ID: 4890805
    [No Abstract]   [Full Text] [Related]  

  • 13. Discoid lupus erythematosus. A study of the clinical features and biochemical and serological abnormalities in 120 patients with observations on the relationship of this disease to systemic lupus erythematosus.
    Beck JS; Rowell NR
    Q J Med; 1966 Jan; 35(137):119-36. PubMed ID: 5329804
    [No Abstract]   [Full Text] [Related]  

  • 14. The nuclear compartment of living cells is not an absolute immunologically sequestered site: evidence for spontaneous intranuclear entry of lupus autoantibodies to living cells.
    Golan TD
    Leukemia; 1997 Jan; 11(1):6-9. PubMed ID: 9001410
    [No Abstract]   [Full Text] [Related]  

  • 15. A complex of intermediate filament protein-DNA: a target for autoantibodies in systemic lupus erythematosus?
    Yan X; Kuhn S; Traub P
    Chin Med Sci J; 1995 Jun; 10(2):90-2. PubMed ID: 7647326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The indirect fluorescent anti-body technic and the diagnosis of the connective tissue diseases.
    Kampmeier RH
    South Med J; 1966 Oct; 59(10):1215 passim. PubMed ID: 4162693
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].
    Kostadinova DA; Razboĭnikov S
    Vutr Boles; 1976; 15(2):18-26. PubMed ID: 59467
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluorescent antinuclear antibody test for lupus erythematosus (FAA).
    Jay AC
    J Indiana State Med Assoc; 1971 Aug; 64(8):840-1. PubMed ID: 4105390
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of antinuclear antibodies in systemic lupus erythematosus].
    Stefanović Z; Mijailović B
    Vojnosanit Pregl; 1986; 43(1):16-21. PubMed ID: 3515753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.